Laden Sie das Bild in Galerie -Viewer, AffiGEN® Transfect(TM) siRNA In Vitro 4000
Laden Sie das Bild in Galerie -Viewer, AffiGEN® Transfect(TM) siRNA In Vitro 4000

SKU: AFG-SNG-TR-024

AffiGEN® Transfect(TM) siRNA In Vitro 4000

Verkäuferin AffiGEN
Regulärer Preis €303,00 EUR
Verkaufspreis €303,00 EUR Regulärer Preis
Verkauf Ausverkauft
Stückpreis
/pro 
Versand An der Kasse berechnet.
Size:
Specifications:
Text vorbestellen

AffiGEN® TransfectTM siRNA In Vitro 4000

Revolutionary Hybrid Formulation for Optimal siRNA Delivery

The AffiGEN® TransfectTM siRNA In Vitro 4000 stands at the forefront of genetic research tools, thanks to its innovative hybrid composition that combines the best aspects of liposome and polymer technologies. This cutting-edge approach ensures not only superior siRNA delivery efficiency but also minimal to no cytotoxicity, setting a new standard in the field.

Contents and Specifications:

AffiGEN® TransfectTM siRNA In Vitro 4000: 1.0 mL, designed for approximately 1330 reactions, assuming the use of 5.0 pmol siRNA per reaction in a 24-well plate format.

AffiGEN® TransfectTM siRNA In Vitro 4000 Buffer (5X): 8.0 mL, engineered to enhance transfection efficiency, yields 40 mL of ready-to-use solution.

Storage Guidelines:

AffiGEN® TransfectTM siRNA In Vitro 4000: Refrigerate at 4 °C.

AffiGEN® TransfectTM siRNA In Vitro 4000 Buffer (5X): Store at room temperature (RT).

Adhering to these conditions will ensure the product remains stable and effective for 12 months or more.

Distinguished Advantages:

Leveraging proprietary technologies in lipid-conjugation and polymer synthesis, AffiGEN® TransfectTM siRNA In Vitro 4000 distinguishes itself from competitors with several key benefits:

  • Unmatched Efficiency: Ideal for transfecting cells that are traditionally challenging, ensuring high-level performance across a diverse range of mammalian cells, all while maintaining virtually undetectable cytotoxicity levels.
  • Cost-Effectiveness: Offers a superior, budget-friendly alternative without compromising on quality or efficacy.

Additional Benefits:

  • Free from sera interference, facilitating consistent and reliable results.
  • Demonstrates exceptional stability for long-term storage and use.
  • Simplified and expedited protocol, saving valuable time in the lab.
  • Fully compatible with high-throughput screening methods, making it perfect for extensive research projects.

AffiGEN® TransfectTM siRNA In Vitro 4000 merges unparalleled efficiency with ease of use, making it an indispensable tool for researchers aiming to push the boundaries of genetic discovery.

siRNA In Vitro Transfection Reagents Specifications and Guide Application

Product AffiGEN® TransfectTM siRNA In Vitro 1000 AffiGEN® TransfectTM siRNA In Vitro 2000 AffiGEN® TransfectTM siRNA In Vitro 3000 AffiGEN® TransfectTM siRNA In Vitro 4000 AffiGEN® TransfectTM siRNA In Vitro 1000 Plus
Nucleic Acid siRNA siRNA, miRNA, DNA siRNA siRNA siRNA
Technology Peptide-based Non-liposomal Liposome formulation Polymer-based Peptide-based
Efficiency High High High High High
Cell compatibility Wide Wide Wide Wide Wide
Off-target effects Low Low Low Low Low
Cytotoxicity Moderate Moderate Low Very Low Moderate
Package sizes 1 mL, 5X 1 mL 1 mL, 5X 1 mL 1 mL, 5X 1 mL 1 mL, 5X 1 mL 1 mL, 5X 1 mL
Storage 4°C, Buffer at RT 4°C, Buffer at RT 4°C, Buffer at RT 4°C, Buffer at RT 4°C, Buffer at RT
Applications Gene silencing, RNAi Gene silencing, miRNA delivery, DNA delivery Gene silencing Gene silencing Gene silencing
Target Organisms Mammalian cells Mammalian cells Mammalian cells Mammalian cells Mammalian cells
Cell Types Suitable For Wide range of cell types Wide range of cell types, including primary cells, stem cells, and difficult-to-transfect cells Wide range of cell types Wide range of cell types, including suspension cells and difficult-to-transfect cells Wide range of cell types, including hard-to-transfect cells
Additional Notes N/A Can be used for in vivo applications N/A Optimized for siRNA delivery, but can also be used for DNA transfection Effective at low concentrations